NS102
From Wikipedia, the free encyclopedia
NS102[1] | ||
---|---|---|
IUPAC name 5-Nitro-6,7,8,9-tetrahydro-1H-benzo[g]indole-2,3-dione 3-oxime | ||
Identifiers | ||
CAS number | 136623-01-3 | |
PubChem | 5282252 | |
Jmol-3D images | {{#if:O=C2NC1=C3C(CCCC3)=C([N+]([O-])=O)C=C1/C2=N/O|Image 1 | |
| ||
Properties | ||
Molecular formula | C12H11N3O4 | |
Molar mass | 261.23 g mol−1 | |
Appearance | Yellow solid | |
Solubility in water | Insoluble | |
Solubility in DMSO | >3 mg/mL | |
(verify) (what is: / ?) Except where noted otherwise, data are given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | ||
Infobox references | ||
NS102 is a kainate receptor ligand.[2][3]
References
- ↑ NS102 at Sigma-Aldrich
- ↑ Johansen, Tina H.; Drejer, Joergen; Watjen, Frank; Nielsen, Elsebet O (1993). "A novel non-NMDA receptor antagonist shows selective displacement of low-affinity [3H]kainate binding". European Journal of Pharmacology 246 (3): 195–204.
- ↑ Dev KK, Petersen V, Honoré T, Henley JM (1996). "Pharmacology and regional distribution of the binding of 6-[3H]nitro-7-sulphamoylbenzo[f]-quinoxaline-2,3-dione to rat brain". J. Neurochem. 67 (6): 2609–12. doi:10.1046/j.1471-4159.1996.67062609.x. PMID 8931496.
|
This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.